Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,280 | -35,308 | -23,766 | -10,692 | -24,690 |
| Depreciation Amortization | 1,247 | 1,163 | 1,123 | 663 | 821 |
| Accounts receivable | -7 | -35 | -171 | -48 | -80 |
| Other Working Capital | 5,989 | -1,849 | 552 | -217 | 164 |
| Other Operating Activity | 2,670 | 1,836 | 970 | 461 | 2,307 |
| Operating Cash Flow | $-47,381 | $-34,193 | $-21,292 | $-9,833 | $-21,478 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 45,735 | 25,895 | 10,623 | 3,425 | -91,657 |
| PPE Investments | -717 | -648 | -158 | -8 | -20 |
| Other Investing Activity | 0 | -769 | -769 | -803 | 0 |
| Investing Cash Flow | $45,018 | $24,478 | $9,696 | $2,614 | $-91,677 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 123 | 40 | 40 | 40 | 75,593 |
| Financing Cash Flow | $123 | $40 | $40 | $40 | $75,593 |
| Beginning Cash Position | 15,801 | 15,101 | 15,101 | 15,101 | 52,663 |
| End Cash Position | 13,561 | 5,426 | 3,545 | 7,922 | 15,101 |
| Net Cash Flow | $-2,240 | $-9,675 | $-11,556 | $-7,179 | $-37,562 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,381 | -34,193 | -21,292 | -9,833 | -21,478 |
| Capital Expenditure | -717 | -648 | -158 | -8 | -20 |
| Free Cash Flow | -48,098 | -34,841 | -21,450 | -9,841 | -21,498 |